India

Pfizer says it is “committed” to work with the center to make the COVID-19 vaccine available in India.

UK approved Pfizer-BioNTech vaccine on Wednesday, UK regulator MHRA granted temporary approval for emergency use

Representative image. PTI

New Delhi: Global pharmaceutical giant Pfizer said Thursday that it remains committed to working with the Government of India to explore opportunities to make Pfizer / BioNTech vaccines available domestically.

The UK on Wednesday became the first country to approve the Pfizer / BioNTech vaccine COVID-19 (new coronavirus infection) (# If there is no character limit, add parentheses when it first appears The Medicines and Healthcare Products Regulatory Agency (MHRA), the UK regulator, has given temporary approval for emergency use.

“We are currently in talks with many governments around the world and are looking for opportunities to make this vaccine available in India,” a Pfizer spokeswoman said in a statement. It was.

Pfizer promised to make the vaccine accessible to everyone and added that it is working closely with the government.

“At this pandemic stage, Pfizer will only supply this vaccine in accordance with regulatory approval or approval through a government contract under agreement with their respective government authorities,” the statement said.

MHRA, a UK regulator, has granted temporary permits for emergency use COVID-19 (new coronavirus infection) (# If there is no character limit, add parentheses when it first appears mRNA vaccine.

Pfizer said Wednesday that it would constitute the first emergency license following a global phase 3 trial of a vaccine to help fight a pandemic.

“We are focusing on acting with the same level of urgency to safely supply high-quality vaccines around the world as further approvals and approvals are expected,” said Pfizer Chairman and Chief Executive Officer. Chief Executive Albert Bourla said Wednesday.

In November, NITI Aayog member (health) VK Paul is also responsible for the National Task Force. COVID-19 (new coronavirus infection) (# If there is no character limit, add parentheses when it first appears , Said that the arrival of the Pfizer vaccine in the country may take several months.

“Placement of a cold chain to store Pfizer-developed vaccines at temperatures as low as minus 70 degrees Celsius is a major challenge and not easy for any country, but even if you need to get it, We’re looking at what we need to do … and we’ll come up with a strategy. “

The Pune-based Serum Institute of India, now in India, has announced that it will apply for an emergency license for the AstraZeneca-Oxford vaccine within two weeks.

Vaccine candidates developed by the indigenous peoples of Bharat Biotech and Phase 3 clinical trials of the Indian Medical Research Council (ICMR) are also underway.

While Zydus Cadila’s vaccine candidate has completed Phase 2 clinical trials, pharmaceutical giant Dr Reddy’s Laboratories has begun a combined Russian Phase 2 and Phase 3 clinical trial. COVID-19 (new coronavirus infection) (# If there is no character limit, add parentheses when it first appears Vaccine, Sputnik V, India.

Another domestic company, Biological E Ltd, has also begun its early Phases 1 and 2 human trials. COVID-19 (new coronavirus infection) (# If there is no character limit, add parentheses when it first appears Vaccine candidate.

Search online for the latest and upcoming tech gadgets with Tech2 Gadgets. Get tech news, gadget reviews and ratings. Popular gadgets for laptops, tablets, mobile specifications, features, prices, comparisons and more.

Pfizer says it is “committed” to work with the center to make the COVID-19 vaccine available in India.

Source link Pfizer says it is “committed” to work with the center to make the COVID-19 vaccine available in India.

Related Articles

Back to top button